Table 2. Patient characteristics.
| Patient | Therapy | Diagnosis Age (years) | Enrollment Age (years) | Time from EOT1 to post-therapy IgG2 levels | Time from EOT to vaccination | Time from vaccination to obtaining IgG levels |
|---|---|---|---|---|---|---|
| 1 | Diagnosis: B-ALL3 Rx4: AALL0932 Duration: 38 months Chemotherapy |
4.4 | 7.8 | 44 days | 4 months | 9 weeks |
| 2 | Diagnosis: T-ALL5 Rx: AALL0434 Duration: 38 months Chemotherapy |
5.5 | 8.10 | 19 days | 4 months | 8 weeks |
| 3 | Diagnosis: B-ALL Rx: AALL1131 Duration: 26 months Chemotherapy |
6.5 | 8.9 | 12 days | 3 months | 5 weeks |
| 4 | Diagnosis: B-ALL Rx: AALL0932 Duration: 26 months Chemotherapy |
8 | 10.3 | 30 days | 4 months | 8 weeks |
| 5 | Diagnosis: Wilms Rx: AREN0532 Duration: 7 months Chemo/Radiation |
9.1 | 9.9 | 35 days | 4 months | 9 weeks |
| 6 | Diagnosis: B-ALL Rx: AALl1131 Duration: 26 months Chemotherapy |
7.3 | 9.8 | 7 days | 3 months | 9 weeks |
| 7 | Diagnosis: B-ALL Rx: AALL0932 Duration: 38 months Chemotherapy |
2.9 | 6.1 | 38 days |
4 months | 10 weeks |
1 End of treatment
2 Immunoglobulin G
3 B-cell acute lymphoblastic leukemia
4 COG protocol type
5 T-cell acute lymphoblastic leukemia